Rhythm Pharmaceuticals RYTM
NASDAQ RYTM
$89.85 +1.23 (+1.39%)
As of: Oct 22, 2026 · 10:35 AM EDT

Rhythm Pharmaceuticals (RYTM) Long-Term Debt Issuances (2022)

Updated

Rhythm Pharmaceuticals' Long-Term Debt Issuances was $24.37 million in FY2023, down 66.3% from $72.34 million in FY2022.

Analysis

Rhythm Pharmaceuticals (RYTM) Long-Term Debt Issuances (2022) Analysis & Trends

  • Per Business Quant data, Long-Term Debt Issuances in earlier years was $72.34 million in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Issuance (Qtr)
1 Eli Lilly 1,163.39 Bn 1,131.97 Bn 19.71 Bn 8.94 Bn
2 Johnson & Johnson 634.39 Bn 552.91 Bn 17.26 Bn -
3 AbbVie 502.68 Bn 475.79 Bn 12.70 Bn -
4 Merck 377.37 Bn 331.74 Bn 12.21 Bn -
5 Novartis Ag 303.41 Bn 267.40 Bn 11.24 Bn 1.98 Bn
6 Astrazeneca 266.55 Bn 240.24 Bn 12.86 Bn -
7 Amgen 240.56 Bn 195.96 Bn 7.24 Bn -
8 Gilead Sciences 193.19 Bn 167.38 Bn 6.22 Bn -
9 Pfizer 172.14 Bn 118.78 Bn 10.94 Bn -
10 Rhythm Pharmaceuticals 6.16 Bn 5.03 Bn 62.32 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 -2.66 Mn
Sep 30, 2022 37.50 Mn
API Access

Rhythm Pharmaceuticals Long-Term Debt Issuances API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-issuances&ticker=RYTM&period=max&api_key=YOUR_API_KEY